Zentalis Pharmaceuticals’ (ZNTL) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) in a research note published on Thursday morning,Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. A number of other analysts also recently commented on the company. UBS Group decreased their price target on Zentalis Pharmaceuticals […]
HC Wainwright reaffirmed their buy rating on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) in a research note published on Thursday morning,Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. A number of other analysts also recently commented on the company. UBS Group decreased their price target on Zentalis Pharmaceuticals […]
